Delivery Order SPE2DB24D2013-SPE2DB24FCHGN

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,612.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order (DO) under DLA's Indefinite Delivery Contract (IDC), covers the provision of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 25, 2024 and is a Firm Fixed Price (FFP) agreement. The award was made...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $1,154.46 delivery order contract is for the supply of JANUMET XR 50-1,000 milligram tablets to support the medical needs of military personnel and other federal beneficiaries. The contract has a period of performance through July 2024. Amerisourcebergen is a well-established government contractor, holding significant Indefinite...
This federal contract award, valued at $1,909.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET XR 50-1,000 MG tablets, with a completion date of June 30, 2023. This award is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization registered in the System for Award...
This federal contract award, valued at $2,823.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG tablets, a pharmaceutical product used in the treatment of diabetes. The contract has a firm fixed price and an ultimate completion date of February 15, 2023. Additionally, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of JANUMET XR 50-1,000 mg tablets. The $4,216.66 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does...
This federal contract award, valued at $3,475.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,252.72, is for the delivery of JANUMET XR 50-1,000 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 17, 2023. The contract is not associated with a set-aside designation....
This federal contract award, valued at $3,499.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, with a completion date of June 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $3,889.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product, with a completion date of January 29, 2025. The contract has a Firm Fixed Price pricing type and does not utilize a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,581.43 Firm Fixed Price Delivery Order covers the supply of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. This award is associated with AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB24FCHGN
    Delivery Order

This federal contract award, valued at $10,490.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET XR 50-1,000 mg tablet prescription medication, with an ultimate completion date of July 29, 2024. This is a firm fixed price delivery order contract, and there is no set-aside designation indicated.

AmerisourceBergen, through its Corporate Office Division, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range of essential pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare, and other federal healthcare programs. The company's extensive supply chain and distribution capabilities make it a key supplier of critical care items, specialty medications, and general pharmaceutical commodities to the U.S. government.

Generated 10/25/24, 9:35 AM